PRME - Prime Medicine, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$17.25
DETAILS
HIGH:
$23.00
LOW:
$12.00
MEDIAN:
$17.00
CONSENSUS:
$17.25
UPSIDE:
480.81%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | -58.1% |
| EBIT Margin | -4342.4% |
| EBITDA Margin | -4226.2% |
| Operating Margin | -4498.1% |
| Pretax Margin | -4342.4% |
| Cont. Ops Margin | -4342.4% |
| Net Margin | -4342.4% |
| Bottom Line Margin | -4342.4% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 4.84 |
| Quick Ratio | 4.84 |
| Solvency Ratio | -0.882 |
| Cash Ratio | 1.68 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-2.57
Peers avg: 9.9
|
| PEG Ratio | 0.14 |
| Forward PEG | 0.14 |
| Price/Book | 4.27 |
| Price/Sales | 111.44 |
| Price/FCF | -3.09 |
| Price/Op Cash Flow | -3.18 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.3397 |
| Debt/Equity | 0.9633 |
| Debt/Capital | 0.4906 |
| Long-Term Debt/Capital | 0.4726 |
| Financial Leverage | 2.84 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.03 |
| Operating Cash Flow Ratio | -4.341 |
| Operating Cash Flow/Sales | -3509.6% |
| Free Cash Flow/Operating Cash Flow | 102.8% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -24.06 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -19.98 |
| Operating Cash Flow Coverage | -1.40 |
| Capital Expenditure Coverage | -35.88 |
| Dividend + Capital Expenditure Coverage | -35.88 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.03 |
| EPS | -1.352 |
| Debt/Share | 0.7827 |
| Cash/Share | 1.19 |
| Book Value/Share | 0.81 |
| Tangible BV/Share | 0.81 |
| Equity/Share | 0.81 |
| Operating Cash Flow/Share | -1.093 |
| Capital Expenditure/Share | 0.030 |
| FCF/Share | -1.123 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.965 |
| Price/Fair Value | 4.27 |
| Debt/Market Cap | 0.2255 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -2.91 |